Objectives To investigate whether endothelial-dependent vasodilation is altered in healthy subjects with a family history of myocardial infarction.
Setting Tertiary University Hospital
Subjects and design Fifty apparently healthy subjects selected from the general population were subjected to an evaluation of endothelial-dependent vasodilation (EDV) and endothelial-independent vasodilation (EIDV) by means of local infusion of methacholine (MCh, 2 and 4 μg/min) and sodium nitroprusside (SNP, 5 and 10 μg/min) with measurements of forearm blood flow with venous occlusion plethysmography. The occurrence of plaque and the intima-media thickness of the carotid arteries were determined by ultrasonography.
Results Subjects reporting at least one parent suffering from myocardial infarction (n=11) showed a significantly lower EDV than subjects without such a family history (21 ± 3.7 vs. 26 ± 6.7 ml/min/100 ml tissue at MCh 4 μg/min, P<0.05). EIDV was not significantly different between the groups (21 ± 6.8 vs. 18 ± 5.4 ml/min/100 ml tissue at SNP 10 μg/min). Age, sex distribution, body mass index, waist to hip ratio, blood pressure, lipids, fasting blood glucose, smoking habits and status of the carotid arteries were not significantly different between the groups.
Conclusion A family history of myocardial infarction was found to be associated with an impaired endothelial-dependent vasodilation in the forearm of apparently healthy subjects. The risk factor profile was not different from the control group, suggesting that genetic factors are responsible for the impaired endothelial-dependent vasodilation.
FurchgottRFZawadskiJV.The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature1980; 299:373–376.
2.
PalmerRMJFerrigeAGMoncadaS.Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature1987; 327:524–526.
3.
PalmerRMJAshtonDSMoncadaS.Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature1988; 333:664–666.
4.
YangisawaMKuriharaHKimuraSTomobeYKobayashiMMitsuiY et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature1988; 332:411–415.
FujiiKTominagaMOhmoriSKobayashiKKogaTTakataYFujishimaM.Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res1992; 70:660–669.
7.
ItoTKatoTIwamaYOkumuraKHashimotoHSatakeT.Prostaglandin H2 as an endothelium-derived contracting factor and its interaction with endothelium-derived nitric oxide. J Hypertens1991; 9:729–736.
8.
GrovesPHBanningAPPennyWJNewbyACCheadleHALewisMJ.The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiovasc Res1995; 30:87–96.
9.
SarkarRMeinbergEGStanleyJCGordonDWebbRC.Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res1996; 78:225–230.
10.
LudmerPLSeiwynAPShockTLWayneRRMudgeGHAlexanderRWGanzP.Paradoxical vasoconstriction induced by acetylcholine in athersclerotic coronary arteries. N Eng J Med1986; 315:1046–1051.
11.
EgashiraKInouTHirookaYYamadaAMaruokaYKaiH et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest1993; 91:29–37.
12.
ManciniGBJHenryGCMacayaCO'NeillBJPucilloALCarereRG et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) study. Circulation1996; 94:258–265.
13.
WwernsSWWaltonJAHsiaHNabelGSanzMLPittB.Evidence for endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation1989; 79:287–291.
14.
ViaJATreasureCBNabelEGMcLenachanJMFishRDYeungAC et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation1990; 81:491–497.
15.
ZeiherAMDrexlerHWollschlägerHJustH.Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation1991; 83:391–401.
16.
LinderLKiowskiWBühlerHLüscherTF.Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: Blunted response in essential hypertension. Circulation1990; 81:1762–1767.
17.
PanzaJAQuyyumiAABrushJEJrEpsteinSE.Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med1990; 323:22–27.
18.
JohnstoneMTCreagerSJScalesKMCuscoJALeeBKCreagerMA.Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation1993; 88:2510–2516.
ChowienczykPJWattsGFCockroftJRRitterJM.Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet1992; 340:1430–1432.
21.
WilliamsSBCuscoJARoddyMAJohnstoneMTCreagerMA.Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol1996; 27:557–567.
ThomasCBCohanBH.The familial occurence of hypertension and coronary artery disease, with observations concerning obesity and diabetes. Ann Intern Med1955; 42:90–99.
24.
KannelWBDawberTRMcNamaraPM.Detection of the coronary prone adult: The Framingham study. J Iowa Med Soc1966; 56:26–32.
25.
DeutchscherSOstranderLDEpsteinFH.Familial factors in premature coronary heart disease – a preliminary report from the Tecumshe Community health study. Am J Epidemiol1970; 91:233–239.
26.
SholtzRIRoesnmanRHBrandRJ.The relationship of reported perental history to the incidence of coronary heart disease in the Western Collaborative Groups Study. Am J Epidemiol1975; 102:350–358.
27.
DeutchscherSEpsteinFHKjelsbergMO.Familial aggregation of factors associated with coronary heart disease. Circulation1966; 33:911–917.
28.
MurphyEA.Genetics in hypertension. A perspective. Circ Res1973; 32:129–135.
29.
LawrieTDVThirdJL.Diet, heredity and heart disease. Proc Nutr Soc1977; 36:69–76.
30.
ClarksonPCelermajerDSPoweAJDonaldAEHenryRMDeanfieldJE.Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation1997; 96:3378–3383.
31.
SchachingerVBrittenMBElsnerMWalterDHScharrerIZeiherAM.A positive history of premature coronary disease is associated with impaired endothelium-dependent coronary blood flow regulation. Circulation1999; 100:1502–1508.
32.
LindLSarabiMMillgårdJ.Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm. Clin Physiol1998; 18:81–87.
33.
LindLHallJLarssonAAnnukMFellströmBLithellH.Evaluation of endothelium-dependent vasodilation in the human peripheral circulation. Clin Physiol2000; 20:440–448.
34.
WangXLSimASBadenhopRFMcCredieRMWilckenDE.A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med1996; 2:41–45.
35.
CambienFPoirierOLecerfLEvansACambouJPVrveilerD et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature1992; 359:641–644.
36.
LindpainterKPfefferMAKreutzRStampferMJGrodsteinFLaMotteF et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. New Engl J Med1995; 332:706–711.
37.
CelermajerDSSorensenKEBarleyJJefferySCarterNDeanfieldJE.Angiotensin-converting enzyme genotype is not associated with endothelial dysfunction in subjects without other coronary risk factors. Atherosclerosis1994; 111:121–126.
